Olmesartan medoxomil self-microemulsifying drug delivery system reverses apoptosis and improves cell adhesion in trinitrobenzene sulfonic acid-induced colitis in rats

Olmesartan medoxomil self-microemulsifying drug delivery system reverses apoptosis and improves cell adhesion in trinitrobenzene sulfonic acid-induced colitis in rats

Olmesartan medoxomil (OM) is an angiotensin receptor blocker. This study aimed to investigate the effects of OM self-microemulsifying drug delivery system (OMS) in trinitrobenzene sulfonic acid (TNBS)-induced acute colitis in rats. Besides two control groups, five TNBS-colitic-treated groups (n = 8)...

Full description

Bibliographic Details
Main Authors: Hussam Murad, Osama Ahmed, Thamer Alqurashi, Mostafa Hussien
Format: Article
Language:English
Published: Taylor & Francis Group 2022-12-01
Series:Drug Delivery
Subjects:
Crohn's disease
olmesartan medoxomil
drug delivery
colitis
E-cadherin
Caspase
Online Access:https://www.tandfonline.com/doi/10.1080/10717544.2022.2086939

Internet

https://www.tandfonline.com/doi/10.1080/10717544.2022.2086939

Similar Items